Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: Role of CD95/CD95L interactions

Blood

Volumn 89, Issue 2, 1997, Pages 558-569

  Accornero, Paola ^b   Radrizzani, Marina ^b   Delia, Domenico ^b   Gerosa, Franca ^b   Kurrle, Roland ^b   Colombo, Mario P ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA FRAGMENT; FAS ANTIGEN; GLYCOPROTEIN GP 120; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; LIGAND; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CROSS LINKING; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE CLONE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031015916     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.558     Document Type: Article

References (60)

1. Radrizzani M, Accornero P, Amidei A, Aiello A, Delia D, Kurrle R, Colombo MP: IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 161:14, 1995
2. Newell MK, Haughn LJ, Maroun CR, Julius MH: Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347:286, 1990
3. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH: Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099, 1992
4. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S: Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392, 1993
5. + lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology 198:360, 1994
6. Terai C, Kornbluth RS, Panza D, Richman DD, Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710, 1991
7. Laurent-Crawford A, Krust B, Muller S, Riviere Y, Rey-Cuillé MA, Bechet JM, Montagnier L, Hovanessian A: The cytopathic effect of HIV is associated with apoptosis. Virology 185:829, 1991
8. Piatak M, Saag MS, Yang LC, Clark SF, Kappes JC, Luk KD, Hahn BH, Shaw GM, Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749, 1993
9. Meyaard L, Otto SA, Jonker RR, Mijnste MJ, Keet RPM, Miedema F: Programmed death of T cells in HIV-1 infection. Science 257:217, 1992
10. Finkel TH, Banda NK: Indirect mechanisms of HIV pathogenesis: How does HIV kill T cells? Curr Opin Immunol 6:605, 1994
11. Pantaleo G, Fauci AS: Apoptosis in HIV infection. Nature Med 1:118, 1995
12. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH: Sensitization of T cell to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 375:497, 1995
13. Gonzalo JA, Moreno de Alboran I, Alés-Martinez JE, Martinez AC, Kroemer G: Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway. Eur J Immunol 22:1007, 1992
14. Wesselborg S, Kabelitz D: Activation-driven death of human T cell clones: Time course kinetics of the induction of cell shrinkage, DNA fragmentation and cell death. Cell Immunol 148:234, 1993
15. Anel A, Buferne M, Boyer C, Schmitt-Verhulst AM, Goldstein P: T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24:2469, 1994
16. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
17. Yang Y, Mercep M, Ware CF, Ashwell JD: Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 181:1673, 1995
18. Dhein J, Walczack H, Bäumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438, 1995
19. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
20. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
21. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM: Role of Interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 93:768, 1994
22. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, Wolf SF, Shearer GM, Henkart PA: Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 91:11811, 1994
23. Romagnani S, Del Prete G, Manetti R, Ravina A, Annunziato F, De Carli M, Mazzetti M, Piccinni MP, D'Elios MM, Parronchi P, Sampognaro S, Maggi E: Role of Th1/Th2 cytokines in HIV infection. Immunol Rev 140:73, 1994
24. Vyakarnam A: Mechanisms for an opposing role for Th1/2 cells in AIDS. Res Immunol 145:618, 1994
25. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, Del Prete G, Romagnani S: Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244, 1994
26. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Med 1:129, 1995
27. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M, Frank I, Trinchieri G: Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J Exp Med 183:2559, 1996
28. Borst J, Van Dongen JJM, De Vries E, Comans-Bitter WM, Van Tol MJD, Kurrle R: BMA-031, a monoclonal antibody suited to identify the T-cell receptor alpha beta/CD3 complex on viable human T lymphocytes in normal and disease states. Hum Immunol 29:175, 1990
29. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620, 1990
30. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nature Med 2:317, 1996
31. Schwartz A, Fernandez-Repollet E: Primary performance parameters as quality control indicators. Flow Cytom Stand Forum 6:9, 1994
32. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
33. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH: gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol 24:928, 1994
34. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78, 1995
35. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schultze-Osthoff K: Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature 375:81, 1995
36. Mariani SM, Matiba B, Baumler C, Krammer PH: Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25:2303, 1995
37. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331, 1992
38. Gougeon ML, Colizzi V, Dalgleish A, Montagnier L: New concepts in AIDS pathogenesis. AIDS Res Hum Retroviruses 9:287, 1993
39. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B: The biochemistry of programmed cell death. FASEB J 9:1277, 1995
40. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos T: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
41. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011, 1993
42. + T cell counts. J Infect Disease 164:631, 1991
43. Seder RA, Grabstein KH, Berzofsky JA, McDyer JF: Cytokine interactions in human immunodeficiency virus-infected individuals: Roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med 182:1067, 1995
44. Navikas V, Link J, Wahren B, Persson C, Link H: Increased levels of interferon-gamma (IFN-γ). IL-4 and transforming growth factor-beta (TGF-β) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 96:59, 1994
45. Heeney JL: AIDS: A disease of impaired Th-cell renewal? Immunol Today 16:515, 1995
46. Rowland-Jones SL, McMichael A: Immune responses in HIV-exposed seronegatives: Have they repelled the virus? Curr Opin Immunol 7:448, 1995
47. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E: Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 93:1293, 1994
48. Kelker HC, Seidlin M, Vogler M, Valentine FT: Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS Res Hum Retroviruses 8:1355, 1992
49. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 90:948, 1993
50. Russel JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7:382, 1995
51. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S: Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 84:2622, 1994
52. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129, 1995
53. Patel T, Gores GJ, Kaufmann SH: The role of proteases during apoptosis. FASEB J 10:587, 1996
54. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH: Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 6:1545, 1994
55. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806, 1995
56. + T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction. Eur J Immunol 25:2679, 1995
57. Debatin KM: High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83:3101, 1994
58. McCloskey TW, Oyaizu N, Kaplan M, Pahwa S: Expression of the Fas antigen in patients with human immunodeficiency virus. Cytometry 22:111, 1995
59. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME, Debatin KM: The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142:175, 1994
60. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 181:2029, 1995